Enhanced Erythrocyte Membrane Exposure of Phosphatidylserine Following Sorafenib Treatment: Anin vivoandin vitroStudy

The impact of erythrocyte age on eryptosis

(2012) Mehrdad Ghashghaeinia et al.   BRITISH JOURNAL OF HAEMATOLOGY

The NFĸB Pathway Inhibitors Bay 11-7082 and Parthenolide Induce Programmed Cell Death in Anucleated Erythrocytes

(2012) Mehrdad Ghashghaeinia et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Protein Kinase CK1α Regulates Erythrocyte Survival

(2012) Christine Zelenak et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Unknown

(2012) Jessie-F Fecteau et al.   MOLECULAR MEDICINE

Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis

(2011) Ying-Hong Shi et al.   Autophagy

Multikinase inhibitor sorafenib exerts cytocidal efficacy against Non-Hodgkin lymphomas associated with inhibition of MAPK14 and AKT phosphorylation

(2011) Bjoern Chapuy et al.   BRITISH JOURNAL OF HAEMATOLOGY

Stimulation of Suicidal Erythrocyte Death by α-Lipoic Acid

(2011) Shefalee K. Bhavsar et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Sphingosine but not Sphingosine-1-phosphate Stimulates Suicidal Erythrocyte Death

(2011) Syed M. Qadri et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Janus Kinase 3 is Expressed in Erythrocytes, Phosphorylated Upon Energy Depletion and Involved in the Regulation of Suicidal Erythrocyte Death

(2011) Shefalee K. Bhavsar et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Stimulation of Suicidal Erythrocyte Death by Benzethonium

(2011) Elisabeth Lang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Dicoumarol Activates Ca2+-permeable Cation Channels Triggering Erythrocyte Cell Membrane Scrambling

(2011) Syed M. Qadri et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

p38 MAPK Activation and Function following Osmotic Shock of Erythrocytes

(2011) Sergios Gatidis et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis

(2011) M. M. Gounder et al.   CLINICAL CANCER RESEARCH

Comparing the Efficacy of Sunitinib with Sorafenib in Xenograft Models of Human Hepatocellular Carcinoma: Mechanistic Explanation

(2011) H. Huynh et al.   CURRENT CANCER DRUG TARGETS

Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation

(2011) Andrea Mancuso et al.   DIGESTIVE AND LIVER DISEASE

Sorafenib: activity and clinical application in patients with hepatocellular carcinoma

(2011) Yong-Song Guan et al.   EXPERT OPINION ON PHARMACOTHERAPY

Sorafenib for the management of advanced renal cell carcinoma

(2011) Bernard Escudier   Expert Review of Anticancer Therapy

Doxorubicin and Sorafenib for Treatment of Advanced Hepatocellular Cancer

(2011) Ghassan K. Abou-Alfa et al.   GASTROENTEROLOGY

Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene

(2011) Syed M. Qadri et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli

(2011) Joan Fernando et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1

(2011) S Huber et al.   LEUKEMIA

Sorafenib: complexities of Raf-dependent and Raf-independent signaling are now unveiled

(2011) Yasunobu Matsuda et al.   Medical Molecular Morphology

Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease

(2011) J. V. Calderón-Salinas et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

A New Rapid and Sensitive LC-MS Assay for the Determination of Sorafenib in Plasma: Application to a Patient Undergoing Hemodialysis

(2011) Christine Bobin-Dubigeon et al.   THERAPEUTIC DRUG MONITORING

Oxidative stress and ERK1/2 phosphorylation as predictors of outcome in hepatocellular carcinoma patients treated with sorafenib plus octreotide LAR

(2011) M Caraglia et al.   Cell Death & Disease

Enhancing the clinical activity of sorafenib through dose escalation: rationale and current experience

(2011) Thomas J. Semrad et al.   Therapeutic Advances in Medical Oncology

Sorafenib induces preferential apoptotic killing of a drug- and radio-resistant hep G2 cells through a mitochondria-dependent oxidative stress mechanism

(2010) Jeng-Fong Chiou et al.   CANCER BIOLOGY & THERAPY

Effect of Amphotericin B on Parasitemia and Survival of Plasmodium Berghei-infected Mice

(2010) Balasaheb Siraskar et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Effect of Anandamide in Plasmodium Berghei-infected Mice

(2010) Diwakar Bobbala et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

FTY720-Induced Suicidal Erythrocyte Death

(2010) Matthias Eberhard et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications

(2010) Johannes Kornhuber et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Monensin Induced Suicidal Erythrocyte Death

(2010) Shefalee K. Bhavsar et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Ceramide in Suicidal Death of Erythrocytes

(2010) Florian Lang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Sorafenib: Rays of Hope in Thyroid Cancer

(2010) Leonidas H. Duntas et al.   THYROID

Predicting the response to sorafenib in hepatocellular carcinoma: where is the evidence for phosphorylated extracellular signaling-regulated kinase (pERK)?

(2009) Andrew X Zhu   BMC Medicine

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudy

(2009) Zhe Zhang et al.   BMC Medicine

Influence of Paclitaxel on Parasitemia and Survival of Plasmodium berghei Infected Mice

(2009) Saisudha Koka et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Accelerated Clearance of Plasmodium-infected Erythrocytes in Sickle Cell Trait and Annexin-A7 Deficiency

(2009) Philipp A. Lang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Suicide for Survival - Death of Infected Erythrocytes as a Host Mechanism to Survive Malaria

(2009) Michael Föller et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Inhibitory Effect of Thymol on Suicidal Erythrocyte Death

(2009) Hasan Mahmud et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Triggering of Suicidal Erythrocyte Death by Amphotericin B

(2009) Hasan Mahmud et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects

(2009) Jorg Hartmann et al.   CURRENT DRUG METABOLISM

Arsenic-induced suicidal erythrocyte death

(2008) Hasan Mahmud et al.   ARCHIVES OF TOXICOLOGY

Eryptosis triggered by bismuth

(2008) Manuel Braun et al.   BIOMETALS

TRPC6 Contributes to the Ca2+ Leak of Human Erythrocytes

(2008) Michael Föller et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Eryptosis, a Window to Systemic Disease

(2008) Florian Lang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Regulation of erythrocyte survival by AMP-activated protein kinase

(2008) Michael Föller et al.   FASEB JOURNAL

Erythrocyte programmed cell death

(2008) Michael Föller et al.   IUBMB LIFE

Anemia and splenomegaly in cGKI-deficient mice

(2008) M. Foller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA